Efficacy and Safety of Long-Acting Reversible Contraception

被引:117
|
作者
Stoddard, Amy [1 ]
McNicholas, Colleen [1 ]
Peipert, Jeffrey F. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Clin Res, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
INTRAUTERINE SYSTEM MIRENA(R); ETONOGESTREL IMPLANT IMPLANON; CLINICAL-PERFORMANCE; LEVONORGESTREL; DEVICES; WOMEN; IUD; EXPERIENCE; PREGNANCY; INSERTION;
D O I
10.2165/11591290-000000000-00000
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Long-acting reversible contraception (LA RC) includes intrauterine devices (IUDs) and the subdermal implant. These methods are the most effective reversible methods of contraception, and have the additional advantages of being long-lasting, convenient, well liked by users and cost effective. Compared with other user-dependent methods that increase the risk of noncompliance-related method failure, LARC methods can bring 'typical use' failure rates more in line with 'perfect use' failure rates. LARC methods are 'forgettable'; they are not dependent on compliance with a pill-taking regimen, remembering to change a patch or ring, or coming back to the clinician for an injection. LARC method failure rates rival that of tubal sterilization at < 1% for IUDs and the subdermal implant. For these reasons, we believe that IUDs and implants should be offered as first-line contraception for most women. This article provides a review of the LARC methods that are currently available in the US, including their effectiveness, advantages, disadvantages and contraindications. Additionally, we dispel myths and misconceptions regarding IUDs, and address the barriers to LARC use.
引用
收藏
页码:969 / 980
页数:12
相关论文
共 50 条
  • [21] Patient Barriers to Discontinuing Long-Acting Reversible Contraception
    Kacie R. Fox
    Alyssa M. Kameoka
    Shandhini Raidoo
    Reni Soon
    Mary Tschann
    Tiana Fontanilla
    Bliss Kaneshiro
    Maternal and Child Health Journal, 2024, 28 : 192 - 197
  • [22] Long-Acting Reversible Contraception: A Review in Special Populations
    Prescott, Gina M.
    Matthews, Christina M.
    PHARMACOTHERAPY, 2014, 34 (01): : 46 - 59
  • [23] Abortion statistics and long-acting reversible contraception in Australia
    Black, Kirsten I.
    Bateson, Deborah J.
    Goldstone, Philip
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2018, 58 (03): : E6 - E7
  • [24] Long-Acting Reversible Contraception: Difficult Insertions and Removals
    Prine, Linda
    Shah, Meera
    AMERICAN FAMILY PHYSICIAN, 2018, 98 (05) : 304 - 309
  • [25] Long-acting reversible methods of contraception: unified training
    Britton, Amanda
    Connolly, Anne
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2014, 40 (02): : 80 - 81
  • [26] Profile of long-acting reversible contraception users in Europe
    Haimovich, Sergio
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2009, 14 (03): : 187 - 195
  • [27] Long-Acting Reversible Contraception: Implants and Intrauterine Devices
    Espey, Eve
    Hofler, Lisa
    OBSTETRICS AND GYNECOLOGY, 2017, 130 (05): : E251 - E269
  • [28] Long-acting reversible contraception side effect management
    Edwards, Alexandra J.
    DiVasta, Amy D.
    Pitts, Sarah
    CURRENT OPINION IN PEDIATRICS, 2020, 32 (04) : 461 - 470
  • [29] Providing Long-acting Reversible Contraception to Adolescents: A Review
    Bahar, Yasmin Z.
    Gold, Melanie A.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2020, 63 (03): : 561 - 573
  • [30] Can Pediatricians Provide Long-Acting Reversible Contraception?
    Norris, Alison H.
    Pritt, Nicole M.
    Berlan, Elise D.
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2019, 32 (01) : 39 - 43